A retrospective analysis of data accumulated over a 21-month period, from December 1989 to September 1991, regarding investigational use of a 308 nanometer Xenon Chloride Excimer Laser Coronary Angioplasty (ELCA) system (Advanced Interventional Systems, Inc., Irvine, CA) was performed.
